Maduramicin, a polyether
ionophore antibiotic, is widely used as an anticoccidial agent in the poultry industry. It has been reported that
maduramicin may cause heart and skeletal muscle cell damage, resulting in
heart failure, skeletal muscle degeneration and even death in animals and humans, if improperly used. However, the molecular mechanism behind its capability to cause death of cardiac cells is not known. Here, we show that
maduramicin induced apoptosis and
necrosis in rat myocardial cells (H9c2).
Maduramicin did not apparently upregulate the expression of
pro-apoptotic proteins (e.g., BAD, BAK and BAX) or downregulate the expression of
anti-apoptotic proteins (e.g. Bcl-2, Bcl-xL, Mcl-1 and
survivin). Interestingly,
maduramicin increased the expression of DR4 and TRAIL, activating
caspases 8/3 and triggering cleavage of
poly ADP ribose polymerase (PARP). In addition,
maduramicin induced nuclear translocation of
apoptosis inducing factor. Furthermore,
maduramicin blocked autophagic flux, as evidenced by inducing accumulation of both LC3-II and p62/SQSTM1. Taken together, the above results suggest that
maduramicin executes its toxicity in the myocardial cells at least by inducing
caspase-dependent cell death through TRAIL/DR4-mediated extrinsic pathway and
caspase-independent cell death by inducing
apoptosis inducing factor nuclear translocation and blocking autophagic flux. Our findings provide a new insight into the molecular mechanism of
maduramicin's toxicity in myocardial cells.